Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Methods from A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants
  1. Home
  2. Publications
  3. Supplementary Methods from A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants

Supplementary Methods from A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants

Authors:
  • YYYan Yang
    Yan Yang
  • ASAvvaru N. Suhasini
    Avvaru N. Suhasini
  • ZJZaoli Jiang
    Zaoli Jiang
  • NLNina Liu
    Nina Liu
  • MRMichael Rosconi
    Michael Rosconi
  • BZBojie Zhang
    Bojie Zhang
  • YLYinyin Li
    Yinyin Li
  • DDDrew Dudgeon
    Drew Dudgeon
  • CSChanghyun Seong
    Changhyun Seong
  • SKSteven Kim
    Steven Kim
  • ARAshique Rafique
    Ashique Rafique
  • THTammy Huang
    Tammy Huang

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/0008-5472.32699897
Abstract
No abstract available
Keywords
  • DRUG MECHANISMS
  • DRUG TARGETS
  • PROTEIN KINASE & PHOSPHATASE DRUG TARGETS
  • GENITOURINARY CANCERS
  • BLADDER CANCER
  • ONCOGENES & TUMOR SUPPRESSORS
  • ONCOGENES
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.